Dideoxy ®ngerprinting (ddF) is a hybrid technique which combines aspects of single strand conformational polymorphism (SSCP) and dideoxy sequencing to detect the presence of single base changes in a de®ned fragment of nucleic acid. ddF is no more technically demanding than SSCP, yet it is more sensitive in detecting point mutations. We describe here the adaptation of conventional ddF to an automated sequencing system usinḡ uorescent Cy5 labeled primers. We show that automated RNA-based ddF (ARddF) has several advantages over conventional radioisotope-based ddF, including: (1) analysis of larger nucleic acid fragments (up to 10 3 bp), due to the ability to continuously analyse and compile sequencing information; (2) greater reliability for distinguishing mutant sequences from wild type sequences (particularly when the mutation leads to gain or loss of a dideoxy termination segment); (3) the use of¯uorescent labeled primers, making ARddF less hazardous than methods requiring radionucleotides. The use of ARddF in conjunction with new methods for isolating RNA from a small number of cells facilitates mutational analysis of small tissue biopsies and other limited samples, and will allow more widespread application of mutational screening in the setting of clinical diagnostic laboratories.
Introduction
Inherited or acquired point mutations play a major role in the pathophysiology of many human diseases (Scriver et al., 1995) . Accurate detection of point mutations can assist in clinical diagnosis and prognosis (Zahurak et al., 1996; Hamada et al., 1996; and thereby in¯uence therapeutic decision making (Chen and Carbone, 1997; Zhang et al., 1995) . A simple, sensitive, speci®c and ecient method for identifying point mutations in nucleic acids is needed. Several methods have been developed and meet these requirements to varying degrees (Grompe, 1993; Olsen et al., 1996) . Manual dideoxy termination sequencing (Sanger et al., 1977) , the accepted standard for identi®cation of alterations in nucleic acid sequences, is both time-and labor-intensive. Recently, single strand conformational polymorphism (SSCP) has emerged as a widely used screening method for identi®cation of point mutations (Orita et al., 1989) . SSCP is relatively easy to perform, but suers from several limitations including a relative lack of sensitivity, relatively small DNA fragments can be evaluated, excessive time required to establish optimal electrophoresis conditions, and an ability to provide information about the relative location of the sequence change (Quiang and Sommer, 1994; Martincic and Whitlock, 1996) . Dideoxy ®ngerprinting (ddF) is a highly sensitive technique which combines aspects of both SSCP and dideoxy sequencing (Sarkar et al., 1992a; Blaszyk et al., 1995) . With ddF, a single dideoxy termination reaction is performed on a nucleic acid fragment of interest, generated by either genomic ampli®cation with transcript sequencing (GAWTS) (Sto¯et et al., 1988) or polymerase chain reaction (PCR) ampli®cation (Martincic and Whitlock, 1996) . The fragments are then denatured and subjected to polyacrylamide gel electrophoresis under nondenaturing conditions which allows fragment separation based on both molecular weight and secondary structure. A point mutation alters the secondary structure of the DNA, leading to altered electrophoretic mobility of one or more termination segments (SSCP component) or production/elimination of a speci®c termination product (dideoxy component) compared to that generated by wild type sequence. ddF oers several advantages over SSCP, including increased sensitivity, ability to analyse larger fragments, estimation of the location of the mutation and easier, more rapid application (Martincic and Whitlock, 1996) . ddF has been used to identify mutations in genes coding for the dopamine D1 receptor (Quiang et al., 1995) , growth hormone (Miyata et al., 1997) , monoamine oxidase (Sobell et al., 1997 ), x-linked severe combined immunode®ciency , BRCA1 (Durocher et al., 1996) , p53 (Martincic and Whitlock, 1996; Blaszyk et al., 1995) , and factor XI (Martincic et al., 1998) . These studies identi®ed mutations in fragments ampli®ed from genomic DNA. However, for mutational screening of larger genes genomic DNA-based ddF remains prohibitively time-consuming and labor-intensive. Using mRNA/cDNA as a template, thereby eliminating intron sequences, circumvents this limitation (Sarkar et al., 1992b) .
Automated sequencing, developed to overcome some of the limitations of manual sequencing, utilizes uorescently labeled primers or deoxynucleotides (dNTPs) in place of radioactive dNTPs. Automated sequencing technology allows simultaneous analysis of a larger number of samples, higher reproducibility, faster data processing and the ability to analyse of longer sequences from a single reaction than manual dideoxy sequencing. ARddF combines the technical advantages of automated sequencing technology with the ability of ddF to detect virtually all mutations in PCR fragments of several hundred bases in size. In this study we compare the ability of automated¯uorescent ddF with that of conventional radioisotopic ddF and standard dideoxy sequencing to identify mutations in the murine p53 gene.
Results and discussion
Friend eythroleukemia virus induces a rapid progressive erythroleukemia in susceptible mice by a two step mechanism: accumulation of infected erythroblasts is followed by speci®c proviral integration that leads to erythroblast immortalization and erythroleukemia clone formation (Moreau-Gachlin et al., 1989; Wendling et al., 1981) . Approximately 30% of leukemic clones transformed by the anemia-inducing strain of Friend erythroleukemia virus contain a mutated p53 allele (Ben-David et al., 1988) . We developed erythroleukemia clones from 35 mice infected with Friend virus (Koury et al., 1997) and analysed them for the presence of point mutations in murine p53 cDNA by both conventional ddF and ARddF. Sequences encompassing p53 exons 3 ± 9 were ampli®ed in two separate PCR ampli®cations for ARddF analysis ( Figure 1 ). For conventional genomic DNA-based ddF analysis each exon was separately ampli®ed due to the large size of intervening introns. All samples were also subjected to standard dideoxy sequencing.
Both conventional ddF and ARddF identi®ed identical point mutations in 21/35 leukemia clones ( Figure 2 ). The two methods showed no dierence in sensitivity and speci®city in regard to detecting point mutations ( Figure 3 ). However, ARddF identi®ed one mutation not initially recognized by conventional ddF: a single base change present in a stretch of closely located termination segments in an area of the gel with poor resolution. This result was consistent with previous reports which suggested that resolution is lost in regions of gels containing termination segments larger than 400 bp. For dideoxy sequencing (and also by implication for ddF), the upper limit of a`highly informative window' was determined to be approximately 400 bp (Quiang and Sommer, 1994; Blaszyk et al., 1995; Liu et al., 1992) . A number of solutions have been proposed to increase the size of this so-called informative window', including: (a) extending the duration of electrophoresis through a nondenaturing gel such that DNA segments 560 bp are electrophoresed from the gel; (b) performing restriction endonuclease ®ngerprinting (REF) (Liu and Sommer, 1995) ; (c) performing bi-directional dideoxy ®ngerprinting (BiddF) (Liu et al., 1992) . We suggest ARddF as an alternative method of increasing the size of PCR fragments which can successfully be analysed. In ARddF,¯uorescently labeled fragments migrating through the gel are excited by a ®xed laser beam, detected by photodiodes and the data is directly stored in the computer for subsequent analysis (ALFexpress DNA sequencer user manual, 1996). The limiting factor in regard to fragment size is no longer the resolving capability of the gel, but rather the ability of cycle sequencing to generate suciently long fragments. As a result, the highly informative window is doubled from 400 bp to 1 Kb. To exemplify this attribute, a segment of mouse p53 cDNA was ampli®ed using primers 1 and 4 (Figure 1 ). The resulting 831 bp PCR fragment was subsequently analysed by manual ddF and ARddF. Sequencing reaction products from this fragment could not be adequately resolved on a 5% polyacrylamide gel. Using conventional ddF in conjunction with MDE gels, mutations residing in the upper part of the gel could not be adequately resolved. However, adequate resolution was obtained for these larger fragments using MDE gels for ARddF. The ability to analyse large PCR fragments increased the eciency of ARddF by reducing the number of PCR/ddF reactions needed to encompass the full length cDNA. RNA from mouse erythroleukemia cell lines was extracted and reverse transcribed. Coding sequence corresponding to exons 3 ± 9 was ampli®ed in two PCR ampli®cations, generating PCR fragment 1 (491 bp; primers 1 and 2) and PCR fragment 2 (426 bp; primers 3 and 4). The entire region was subsequently ampli®ed using primers 1 and 4, generating 831 bp PCR fragment 3. PCR fragments were subjected to ddF analysis Figure 2 Spectrum of mutations in the analysed segment of the mouse p53 coding sequence. PCR fragments of the mouse p53 coding sequence were screened with ddF for the presence of point mutations. Samples scored positive by ddF were subsequently sequenced with dideoxytermination sequencing. p53 mRNA was either mutated or disrupted in 21/35 erythroleukemia clones. The majority of mutations were located in exons 6 ± 8. Mutation of codon 275 was present in 3/21 mutated clones A common problem in analysing tumor samples is the sensitivity of the assay in identifying mutations because of the dilution of tumor cell DNA by wild-type DNA from normal cells. Since the ratio of these two components may vary greatly from one sample to another, we determined the minimum percentage of mutant cells required to successfully identify point mutations by ARddF. Cells from two erythroleukemia clones, containing either wild-type p53 (from EL11) or mutated p53 (from EL12), were combined in ratios from 0.05 to 1.0 EL11/EL12 cells and analysed with manual ddF and ARddF (Figure 4 ). The two methods demonstrated similar sensitivities. The minimum percentage of mutated cells required for identi®cation of mutations was found to be dependent upon the type of change in secondary structure caused by the mutation: mutations with a dideoxy component required a minimum of 10% EL12 cells containing mutant p53, while an electrophoretic band shift generated by a predominant SSCP component was identi®ed in a mixture containing only 5% EL12 cells.
In summary, we have successfully adapted ddF to an automated sequencing system. Furthermore, we have shown that ARddF (a) has improved sensitivity compared to conventional radioactivity-based ddF, due to its ability to resolve mutations located in areas of low resolution on standard ddF gels; (b) is able to analyse larger fragments with fast, objective and reproducible data analyses; and (c) eliminates the potential hazards associated with radioactivity. Finally, the capacity of the automatic sequencer to simultaneously analyse 40¯uorescent dye-labeled samples makes ARddF particularly suitable for clinical laboratory diagnostics.
Materials and methods

Cell lines
Erythroleukemia cell lines were derived from CD 2 F 1 mice infected with 10 3 spleen focus-forming units of the anemia inducing strain of Friend leukemia virus as previously described (Koury et al., 1997) . When the mice developed signs of leukemia, they were sacri®ced and their spleens removed. Spleens were minced and passed through nylon mesh bags to generate single cell suspensions. Cells were cultured without the addition of growth factors in Iscove's modi®cation of Dulbecco's medium with 0.8% methylcellulose, 30% fetal bovine serum, 1% deionized BSA, 100 mmol/L a-thioglycerol, 100 U of penicillin and 100 mg/ml of streptomycin. Colonies were isolated and propagated as continuous cell lines as described previously (Koury et al., 1997) .
RNA extraction and reverse transcription (RT)
Total RNA was extracted from erythroleukemia cell lines using a standard guanidine thiocyanate (GTC) extraction procedure (Chomcynski and Sacchi, 1986) . Thirty to forty million cells were homogenized in 2 ml of RNA extraction solution containing 4 M GTC, 25 mM sodium citrate pH 7.0, 0.5% sarcosyl and 0.1 M b-mercaptoethanol. Then, 0.2 ml of 2 M sodium acetate, pH 4.0, 2.2 ml of phenol, pH 4.0 and 0.4 ml of chloroform-isoamyl alcohol mixture (24 : 1) were sequentially added to the homogenate and thoroughly mixed. The ®nal solution was incubated on ice for 15 min and centrifuged for 20 min at 48C. The aqueous phase was transferred to a fresh tube and RNA was precipitated with an equal volume of isopropanol for 2 h at 7208C, followed by centrifugation for 20 min at 10 000 r.p.m. The RNA pellet was dissolved in RNA extraction solution, precipitated with isopropanol, centrifuged, and dissolved in diethylpyrocarbonate treated water. For smaller numbers (10 5 to 10 6 ) of cells, RNA was isolated with a Poly A Tract System 1000 (Promega) according to the manufacturer's instructions. Five micrograms of total RNA were reverse transcribed using a Ready-To-Go T-Primed First-Strand Kit(Pharmacia). 
Polymerase chain reaction (PCR) ampli®cation
Two microliters of RT reaction were ampli®ed in a ®nal volume of 50 ml containing 106TaKaRa reaction buer [PanVera], 1.5 mM magnesium chloride, 100 mM of each deoxyribonucleoside triphosphate (dNTP), 10 pmol of each primer and 2.5 U of TaKaRa LA Taq polymerase. The resulting mixture was initially denatured at 948C for 3 min, followed by annealing at 648C for 45 s and elongation at 728C for 1 min. Subsequently, an additional 34 cycles of denaturation at 948C for 45 s, annealing at 648C for 30 s and elongation at 728C for 1 min were performed using a PTC-100 thermal cycler (MJ Research). Primers used in the PCR reaction were based on a published murine p53 coding sequence (Penica et al., 1984) as follows: primer 1 5'-ATCTGTTGCTGCCCCAGGATGTTG-3'
(positions 285 ± 308); primer 2 5'-CCTGTCTTCCAGATACTCGG-GATAC-3' (positions 772 ± 751); primer 5'-AGAAGTCA-CAGCACATGACGGAGG-3'
(positions 639 ± 662); primer 4 5'-TGGTTTTTTCTTTTGCGGGGGAGAGG-3' (positions 1114 ± 1089) (Figure 1) . The resulting PCR fragments were subjected to electrophoresis on a 2% NuSieve gel, cut out and puri®ed using a QIAEX DNA puri®cation kit (Qiagen).
Dideoxy ®ngerprinting (ddF) and dideoxy sequencing ddF/sequencing reactions were performed in a total volume of 8.0 ml containing 20 mM Tris-HCl, pH 8.4, 50 mM KCl, 2 mM MgCl 2 , 20 mM of each dNTP, 100 mM of ddGTP, 1 pmol of desired primer, 0.25 U of Taq DNA Polymerase (Gibco/BRL) and 5 ± 15 ng of puri®ed PCR fragment. The sequencing reactions were performed on a PTC-100 thermal cycler using the following cycling parameters: denaturation at 948C for 45 s, annealing at 648C for 30 s and elongation at 728C for 1 min (the 831 bp fragment elongation time was extended to 2 min). After cycling, 16 ml of loading buer was added to each reaction. Conventional radioisotopic ddF was performed using a Sequi-Gen GT Sequencing Cell (Bio-Rad) with 8% PAGE/10% glycerol gels or 0.56MDE gels. PCR fragment 3 (831 bp) was analysed on 0.36MDE gel. Electrophoresis was performed with 0.56 standard Trisboric acid-EDTA (TBE) buer at 30 W constant power with a constant temperature of 22 ± 258C. Fluorescentbased ddF was performed using an automated ALFexpress DNA sequencer (Amersham Pharmacia Biotech) under electrophoretic conditions identical to those used for conventional ddF. DNA primers were labeled with Cy5 amidite (Amersham Pharmacia Biotech). Data analysis was performed using ALF Manager V3.0 software and analysed using Fragment manager V1.2 software (Amersham Pharmacia Biotech). 
